secwatch.observer — SEC 8-K summary
======================================

Issuer:     GoodRx Holdings, Inc. (GDRX)
CIK:        0001809519
Form:       8-K
Filed at:   2026-08-05T20:09:49+00:00
Accession:  0001809519-26-000153
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
LLM model:  deepseek-v4-flash:cloud@v2

GoodRx appoints Justin Fengler as CFO, replacing Christopher McGinnis
---------------------------------------------------------------------

- Christopher McGinnis to step down as CFO & Treasurer effective Aug 5, 2026; departure not due to disagreement.
- Justin Fengler, current Chief Strategy & Operations Officer, appointed CFO & Treasurer effective Aug 6, 2026.
- Fengler receives $600k RSU, $600k PSU, $100k cash, and Tier 1 severance plan designation.
- McGinnis expected to receive severance per Tier 1 plan and sign separation agreement with non-disparagement.
- Fengler has been with GoodRx since 2016, previously SVP of Corporate Strategy & Business Operations.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1809519/000180951926000153/0001809519-26-000153-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1809519/000180951926000153/gdrx-20260731.htm
  HTML page:      https://secwatch.observer/filing/0001809519-26-000153

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer